2026 Quick Summary
- • Tirzepatide remains the most effective weight loss injection available (up to 22.5% body weight lost)
- • Semaglutide now has 5+ years of real-world safety data and proven cardiovascular benefits
- • Oral Semaglutide (Rybelsus) is gaining traction for injection-averse patients
- • Retatrutide (triple agonist) is in Phase 3 trials — may be available in 2026-2027
- • Miami Injections pricing: Semaglutide from $299/mo, Tirzepatide from $399/mo
- • Board-certified physician oversight is more important than ever as unregulated sellers proliferate
The State of Weight Loss Injections in Miami in 2026
If you searched "weight loss injections Miami" in 2026, you found a very different landscape than 2023. GLP-1 medications have gone from niche pharmaceutical products to mainstream household names. Ozempic, Wegovy, Mounjaro, and Zepbound are referenced in news articles, social media, and dinner conversations across Miami-Dade. The demand for these treatments has never been higher.
But with that demand has come a flood of unregulated sellers, telehealth mills, and compounding pharmacies operating outside FDA guidelines. In 2026, knowing who is prescribing your medication and what oversight standards they follow is more important than ever. This guide covers everything you need to know about weight loss injections in Miami in 2026.
Semaglutide in Miami 2026: What's Changed
Semaglutide (the active ingredient in Ozempic and Wegovy) has now been in widespread clinical use for over 5 years. The long-term data is in, and it's compelling:
SELECT Trial Confirmation
The SELECT cardiovascular outcomes trial (17,604 patients) confirmed a 20% reduction in major cardiovascular events for patients on Semaglutide. This is now a primary reason physicians prescribe it for patients with cardiovascular risk factors.
Cognitive Benefits Emerging
New 2025-2026 research suggests Semaglutide may reduce risk of Alzheimer's disease and cognitive decline. While not yet FDA-approved for this indication, the data is generating significant scientific interest.
NASH/MASH Approval
Semaglutide received FDA approval for metabolic-associated steatohepatitis (MASH/NASH) in 2024, expanding its clinical utility for patients with fatty liver disease.
Pricing in 2026
Brand-name Wegovy remains $1,000-$1,400/month without insurance. Compounded Semaglutide from licensed providers like Miami Injections starts at $299/month — the same active molecule at a fraction of the cost.
Tirzepatide in Miami 2026: Still the Most Effective
Tirzepatide (Mounjaro/Zepbound) remains the most effective weight loss injection available in 2026. The SURMOUNT-5 trial, published in late 2024, directly compared Tirzepatide to Semaglutide head-to-head and confirmed Tirzepatide's superiority: patients on Tirzepatide lost approximately 47% more weight than those on Semaglutide.
2026 Clinical Data: Average Weight Loss
Sources: SURMOUNT-1 (Tirzepatide), STEP-1 (Semaglutide 2.4mg). Average % body weight loss in clinical trial participants.
What's New in 2026: Emerging Treatments
Retatrutide (Triple Agonist)
Phase 3 TrialsEli Lilly's retatrutide activates GLP-1, GIP, AND glucagon receptors simultaneously. Phase 2 data showed up to 24.2% weight loss at 48 weeks — potentially the most effective obesity medication ever studied. Phase 3 results expected in 2026.
Oral Semaglutide (Rybelsus)
Available NowFor patients who prefer not to inject, oral Semaglutide (Rybelsus) is now widely available. Weight loss is slightly less than injectable Semaglutide, but the convenience factor is significant for many patients.
Cagrilintide + Semaglutide (CagriSema)
Phase 3 TrialsNovo Nordisk's combination of cagrilintide (amylin analog) and Semaglutide showed 22.7% weight loss in Phase 3 trials. Expected FDA submission in 2026.
Amycretin
Phase 2 TrialsA novel oral GLP-1/amylin co-agonist showing promising early data. If approved, it would be the first oral dual-mechanism weight loss medication.
Why Board-Certified Oversight Matters More in 2026
The proliferation of GLP-1 medications has unfortunately also brought a proliferation of unregulated sellers. In 2025-2026, the FDA issued multiple warning letters to compounding pharmacies producing substandard or mislabeled Semaglutide and Tirzepatide. Patients who purchased from unregulated sources reported receiving incorrect concentrations, contaminated products, and medications without proper physician oversight.
At Miami Injections, every prescription is issued by a board-certified Florida physician after a thorough medical evaluation. Our medications come from licensed 503B compounding pharmacies operating under FDA oversight. This is not a formality — it is the difference between safe, effective treatment and a potentially dangerous shortcut.
Board-Certified Physicians
Every prescription from a licensed Florida MD
Licensed 503B Pharmacies
FDA-overseen compounding facilities only
Real Miami Office
917 SW 87th Ave, Sweetwater FL 33174
Human Support
Call (305) 490-2240 — a person answers
2026 Pricing: Miami Injections vs Competitors
| Provider | Semaglutide | Tirzepatide | In-Person Office |
|---|---|---|---|
| Miami Injections (us) | From $299/mo | From $399/mo | |
| Henry Meds | From $297/mo | From $449/mo | |
| Ro (Body) | From $299/mo | From $449/mo | |
| Hims/Hers | From $299/mo | From $449/mo | |
| Brand-name Wegovy/Zepbound | $1,000-$1,400/mo | $1,000-$1,400/mo |
Pricing as of April 2026. Competitor pricing sourced from public websites. Miami Injections pricing includes physician evaluation, medication, supplies, and ongoing support. See our full pricing page.
Miami Neighborhoods We Serve in 2026
Miami Injections serves all of Miami-Dade County from our clinic at 917 SW 87th Ave, Sweetwater FL 33174. We have dedicated neighborhood pages for the following areas:
Frequently Asked Questions — Weight Loss Injections Miami 2026
In 2026, the two most effective weight loss injections available in Miami are Tirzepatide (Mounjaro/Zepbound) and Semaglutide (Ozempic/Wegovy). Tirzepatide produces greater average weight loss (up to 22.5% body weight) due to its dual GIP/GLP-1 mechanism. Semaglutide produces approximately 14.9% average weight loss and has proven cardiovascular benefits. Both are available at Miami Injections with board-certified physician supervision from $299/month.
At Miami Injections in 2026, Semaglutide programs start at $299/month and Tirzepatide programs start at $399/month. B12 + lipotropic injections are $35/shot. These prices include physician evaluation, medication, supplies, and ongoing support. Brand-name alternatives (Wegovy, Zepbound) can cost $1,000-$1,400/month without insurance.
Tirzepatide produces greater average weight loss than Semaglutide in clinical trials (20.9% vs 14.9% at maximum doses). However, Semaglutide has a longer safety track record and proven cardiovascular benefits from the SELECT trial. The best choice depends on your individual health profile, goals, and medical history. Our board-certified physicians will recommend the right treatment during your free consultation.
Miami Injections (B12 Miami) at 917 SW 87th Ave, Sweetwater FL 33174 is Miami-Dade's most reviewed weight loss injection clinic with a 5.0/5 Google rating. We offer Semaglutide from $299/month, Tirzepatide from $399/month, and B12 lipotropic injections from $25/shot. Board-certified physician supervision, same-day appointments, and bilingual English/Spanish service. Call (305) 490-2240.
In 2026, the primary GLP-1 medications available in Miami are Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound). Oral Semaglutide (Rybelsus) is also available for patients who prefer not to inject. Retatrutide (triple GIP/GLP-1/glucagon agonist) is in Phase 3 trials and may receive FDA approval in 2026-2027. Our physicians stay current with all emerging treatments.
Yes. Miami Injections ships Semaglutide and Tirzepatide throughout Florida and all 50 states. After your physician consultation (in-person or telehealth), your medication ships within 24 hours. Miami-Dade patients typically receive same-day or next-day delivery. We also offer in-office pickup at 917 SW 87th Ave, Sweetwater FL 33174.